Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1988 2
1989 2
1991 2
1992 5
1993 1
1994 7
1995 4
1996 3
1997 7
1998 5
1999 6
2000 2
2001 3
2002 9
2003 8
2004 6
2005 7
2006 5
2007 5
2008 8
2009 6
2010 7
2011 9
2012 5
2013 8
2014 11
2015 6
2016 10
2017 3
2018 5
2019 8
2020 4
2021 8
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Cystic fibrosis.
Rowe SM, Miller S, Sorscher EJ. Rowe SM, et al. Among authors: sorscher ej. N Engl J Med. 2005 May 12;352(19):1992-2001. doi: 10.1056/NEJMra043184. N Engl J Med. 2005. PMID: 15888700 No abstract available.
Engineered tRNAs suppress nonsense mutations in cells and in vivo.
Albers S, Allen EC, Bharti N, Davyt M, Joshi D, Perez-Garcia CG, Santos L, Mukthavaram R, Delgado-Toscano MA, Molina B, Kuakini K, Alayyoubi M, Park KJ, Acharya G, Gonzalez JA, Sagi A, Birket SE, Tearney GJ, Rowe SM, Manfredi C, Hong JS, Tachikawa K, Karmali P, Matsuda D, Sorscher EJ, Chivukula P, Ignatova Z. Albers S, et al. Among authors: sorscher ej. Nature. 2023 Jun;618(7966):842-848. doi: 10.1038/s41586-023-06133-1. Epub 2023 May 31. Nature. 2023. PMID: 37258671 Free PMC article.
High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo.
Huayamares SG, Lokugamage MP, Rab R, Da Silva Sanchez AJ, Kim H, Radmand A, Loughrey D, Lian L, Hou Y, Achyut BR, Ehrhardt A, Hong JS, Sago CD, Paunovska K, Echeverri ES, Vanover D, Santangelo PJ, Sorscher EJ, Dahlman JE. Huayamares SG, et al. Among authors: sorscher ej. J Control Release. 2023 May;357:394-403. doi: 10.1016/j.jconrel.2023.04.005. Epub 2023 Apr 12. J Control Release. 2023. PMID: 37028451 Free PMC article.
Cystic fibrosis precision therapeutics: Emerging considerations.
Joshi D, Ehrhardt A, Hong JS, Sorscher EJ. Joshi D, et al. Among authors: sorscher ej. Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S13-S17. doi: 10.1002/ppul.24547. Pediatr Pulmonol. 2019. PMID: 31715091 Free PMC article. Review.
Transformative therapies for rare CFTR missense alleles.
Oliver KE, Han ST, Sorscher EJ, Cutting GR. Oliver KE, et al. Among authors: sorscher ej. Curr Opin Pharmacol. 2017 Jun;34:76-82. doi: 10.1016/j.coph.2017.09.018. Epub 2017 Oct 13. Curr Opin Pharmacol. 2017. PMID: 29032041 Free PMC article. Review.
PNP anticancer gene therapy.
Zhang Y, Parker WB, Sorscher EJ, Ealick SE. Zhang Y, et al. Among authors: sorscher ej. Curr Top Med Chem. 2005;5(13):1259-74. doi: 10.2174/156802605774463105. Curr Top Med Chem. 2005. PMID: 16305530 Review.
CFTR modulator theratyping: Current status, gaps and future directions.
Clancy JP, Cotton CU, Donaldson SH, Solomon GM, VanDevanter DR, Boyle MP, Gentzsch M, Nick JA, Illek B, Wallenburg JC, Sorscher EJ, Amaral MD, Beekman JM, Naren AP, Bridges RJ, Thomas PJ, Cutting G, Rowe S, Durmowicz AG, Mense M, Boeck KD, Skach W, Penland C, Joseloff E, Bihler H, Mahoney J, Borowitz D, Tuggle KL. Clancy JP, et al. Among authors: sorscher ej. J Cyst Fibros. 2019 Jan;18(1):22-34. doi: 10.1016/j.jcf.2018.05.004. Epub 2018 Jun 20. J Cyst Fibros. 2019. PMID: 29934203 Free PMC article. Review.
Nucleic acid-based drugs for patients with solid tumours.
Huayamares SG, Loughrey D, Kim H, Dahlman JE, Sorscher EJ. Huayamares SG, et al. Among authors: sorscher ej. Nat Rev Clin Oncol. 2024 Jun;21(6):407-427. doi: 10.1038/s41571-024-00883-1. Epub 2024 Apr 8. Nat Rev Clin Oncol. 2024. PMID: 38589512 Review.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
Tedbury PR, Manfredi C, Degenhardt F, Conway J, Horwath MC, McCracken C, Sorscher AJ, Moreau S, Wright C, Edwards C, Brewer J, Guarner J, de Wit E, Williamson BN, Suthar MS, Ong YT, Roback JD, Alter DN, Holter JC, Karlsen TH, Sacchi N, Romero-Gómez M, Invernizzi P, Fernández J, Buti M, Albillos A, Julià A, Valenti L, Asselta R, Banales JM, Bujanda L, de Cid R, Franke A; Severe COVID-19 GWAS group; Sarafianos SG, Hong JS, Sorscher EJ, Ehrhardt A. Tedbury PR, et al. Among authors: sorscher ej. FASEB J. 2023 Nov;37(11):e23220. doi: 10.1096/fj.202300077R. FASEB J. 2023. PMID: 37801035
190 results